Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
5.06M
-
Shares change
-
+463K
-
Total reported value, excl. options
-
$14.9M
-
Value change
-
+$1.37M
-
Put/Call ratio
-
0.77
-
Number of buys
-
10
-
Number of sells
-
-13
-
Price
-
$2.95
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2024
37 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q2 2024.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.06M shares
of 51.9M outstanding shares and own 9.75% of the company stock.
Largest 10 shareholders include COOPERMAN LEON G (1.4M shares), VANGUARD GROUP INC (1.02M shares), FIRST MANHATTAN CO. LLC. (839K shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (483K shares), Bleichroeder LP (382K shares), GEODE CAPITAL MANAGEMENT, LLC (237K shares), NORTHERN TRUST CORP (120K shares), Aristides Capital LLC (106K shares), BlackRock Inc. (105K shares), and MORGAN STANLEY (86.2K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.